Dendritic cell-activated cytokine-induced killer cells - Shanghai Jia Fu Medical

Drug Profile

Dendritic cell-activated cytokine-induced killer cells - Shanghai Jia Fu Medical

Alternative Names: Autologous dendritic cell cytokine-induced killer cell therapy - Shanghai Jia Fu Medical; DC CIK biotherapy - Shanghai Jia Fu Medical Apparatus; DC-activated CIK - Shanghai Jia Fu Medical Apparatus; DC-CIK - Shanghai Jia Fu Medical Apparatus; DCIK - Shanghai Jia Fu Medical Apparatus; Dendritic cell cytokine-induced killer cell therapy - Shanghai Jia Fu Medical

Latest Information Update: 18 Jul 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Shanghai Jia Fu Medical Apparatus
  • Class Cell therapies; Dendritic cell vaccines
  • Mechanism of Action Cytokine induced killer cell modulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Cancer

Most Recent Events

  • 13 Jul 2012 Product launched for Cancer (Parenteral) before July 2012
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top